NCT00514007View on ClinicalTrials.gov

Study of Continuous OSI-906 Dosing

PHASE1CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

June 18, 2007

Primary Completion Date

March 19, 2012

Study Completion Date

March 19, 2012

Conditions
Advanced Solid Tumors
Interventions
DRUG

OSI-906

OSI-906 administered orally

Trial Locations (2)

37232-6307

Vanderbilt Universtiy Medical Center, Nashville

G12 0YN

The Beatson West of Scotland Cancer Centre, Glasgow

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY